Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:N-Undecylbenzenesulfonic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004291 AN007136 Metabolomics analysis of Plasmodium falciparum asexual-stage parasites treated with plasmepsin V peptidomimetics - 16 hour treatment Blood Plasmodium falciparum Malaria Monash University LC-MS
ST004290 AN007134 Metabolomics characterisation of Plasmodium falciparum response to plasmepsin V peptidomimetic inhibitors - 5 hour treatment Blood Plasmodium falciparum Malaria Monash University LC-MS
ST004227 AN007036 Comparative untargeted metabolomics analysis the wheat grains in cultivars zhengmai 7698 and zhoumai 22 Seeds Wheat Henan Academy of Agricultural Sciences LC-MS
ST004194 AN006967 PfK13-associated artemisinin resistance slows drug activation and enhances antioxidant defence, which can be overcome with sulforaphane Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST004153 AN006895 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST003880 AN006373 Untargeted metabolome analysis of control and disease intervertebral disc tissue Tissue Human Bone disease Ganga Orthopaedic Research and Education Foundation LC-MS
ST003655 AN006005 Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor Blood Human Cancer Universitätsspital Zürich MALDI-MS
ST003655 AN006005 Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor Blood Mouse Cancer Universitätsspital Zürich MALDI-MS
ST003639 AN005977 Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells Cultured cells Human Cancer Portuguese Oncology Institute of Porto (IPO-Porto) LC-MS
ST003521 AN005783 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University LC-MS
ST003160 AN005185 New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST003128 AN005128 Effect of high fat diet on serum lipidome and metabolome in CHCHD10 Mutant Mice Blood Mouse Cardiomyopathy Weill Cornell Medicine LC-MS
ST003053 AN005007 Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics Bacterial cells Staphylococcus aureus Bacterial infection Monash University LC-MS
ST002926 AN004799 Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002461 AN004016 Untargeted metabolomics of HUVECs subjected to hypoxia-reoxygenation Cultured cells Human Hypoxia Tulane University School of Medicine LC-MS
ST002107 AN003447 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002106 AN003445 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002104 AN003440 Chemoresistant Cancer Cell Lines are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations Cultured cells Human Cancer Future Industries Institute LC-MS
ST002010 AN003276 Chemoresistant Ovarian Cancer Global Metabolomics Cultured cells Human Cancer University of South Australia LC-MS
ST001304 AN002173 Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii Fibroblast cells Toxoplasma gondii Parasitic infection Monash University LC-MS
ST001205 AN002007 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001205 AN002007 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001202 AN002001 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001202 AN002001 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001175 AN001951 Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST000221 AN000330 Normal plasma cells,Low proliferation multiple myeloma and High proliferation multiple myeloma cells Bone marrow Human Cancer Mayo Clinic LC-MS
  logo